News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement
|Articles|October 26, 2004

ITF-Levoxyl

Author(s)Pharmaceutical Technology Editors

Pharmaceutical science and technology news

Advertisement
External Link - article-130642.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Advertisement

Related Content

Advertisement
Leukemia Awareness: Photomicrograph of bone marrow aspirate showing myeloblasts of acute myeloid leukemia (AML), a cancer of white blood cells. | Image Credit: ©David A Litman -stock.adobe.com

Amgen Acquires UK Biotech Dark Blue Therapeutics

BySusan Haigney
January 6th 2026

Industry Outlook 2026: Trends Transitioning from 2025 into 2026

BySusan Haigney
January 6th 2026
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP

BySusan Haigney
January 6th 2026

Making Smart Decisions and Investments in Trained Staff Key to 2026 Success

BySusan Haigney
January 5th 2026

Quick Execution with Operational Integrity

BySusan Haigney
January 5th 2026
Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

From AI to Smart Factories: How Pharma Is Preparing for 2026

2

Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP

3

Industry Outlook 2026: Success through Top Talent, AI Utilization, and Sustainability

4

FUJIFILM Irvine Scientific Becomes FUJIFILM Biosciences

5

Amgen Acquires UK Biotech Dark Blue Therapeutics

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us